Balyasny Asset Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,000
Closed -$706K 2959
2025
Q4
$706K Hold
7,000
﹤0.01% 2355
2025
Q3
$863K Sell
7,000
-300
-4% -$37.2K ﹤0.01% 2174
2025
Q2
$877K Sell
7,300
-1,500
-17% -$200K ﹤0.01% 2085
2025
Q1
$1.3M Buy
+8,800
New +$1.34M ﹤0.01% 1887
2024
Q4
Sell
-19,200
Closed -$3.13M 2808
2024
Q3
$3.13M Buy
+19,200
New +$2.85M 0.01% 1475
2023
Q1
Sell
-2,200
Closed -$309K 2710
2022
Q4
$309K Buy
+2,200
New +$312K ﹤0.01% 1981
2021
Q2
Sell
-50,000
Closed -$9.64M 2013
2021
Q1
$9.64M Buy
+50,000
New +$9.62M 0.05% 497
2020
Q2
Sell
-80,000
Closed -$13.9M 1165
2020
Q1
$13.9M Buy
+80,000
New +$13.2M 0.16% 176
2013
Q4
Sell
-200,000
Closed -$4.38M 509
2013
Q3
$4.38M Buy
+200,000
New +$16.9M 0.06% 367

Other funds holding CLX

Balyasny Asset Management's CLX Position: Q1 2026 in Review

Balyasny Asset Management reduced its Clorox (CLX) stake by 4.2% in Q1 2026, selling an estimated $819K and leaving 163,733 shares worth $17M. The position accounts for 0.02% of the portfolio, ranked #756.

Balyasny Asset Management first reported a position in CLX in Q4 2015 and has held it in 28 quarters since. The position peaked at $231M in Q4 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Balyasny Asset Management held 163,733 shares of Clorox worth $17M as of Q1 2026.
  • Balyasny Asset Management sold 7,225 Clorox shares in Q1 2026, an estimated $819K.
  • Clorox made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #756 holding.
  • Balyasny Asset Management first reported a position in Clorox in Q4 2015 and has held it in 28 quarters since.
  • Balyasny Asset Management's Clorox position peaked at $231M in Q4 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.